LCN2 and colitis: In the Winnie mouse model of colitis, APX3330 reduced the amount of CD45‐positive leukocytes in the colon and the levels of inflammatory marker, lipocalin‐2 (Lcn‐2), in fecal pellets (Sahakian et al., 2020).